Grodt SRL
Grodt reported total assets of 109,794 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).
The score of Grodt shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +2 % Total assets +17 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Grodt's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 31 Dec 2024
Grodt's financial analysis
- Solvency25.1%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Grodt
Grodt's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0789.571.288
- VAT number
- BE0789571288
- Peppol
- Registered · 0208:0789571288 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Aug 2022
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Grodt (SRL) has been based in Uccle since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 19,041 € and equity of 27,515 €; its revenue is not published. Its solvency stands at 25.1%, below the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Grodt
Companies in the same business, of comparable size and area, outside its group.
- Societe Pharmaceutique de Gestion Retail sale of pharmaceutical products Ixelles · balance sheet 86,711 €
- Pharma Nasir Retail sale of pharmaceutical products Ixelles · balance sheet 126,608 €
- Selvipharma Retail sale of pharmaceutical products Brussels · balance sheet 109,734 €
- Apotheek Spaanse Kroon Retail sale of pharmaceutical products Leuven · balance sheet 110,316 €
- Pharmanou Retail sale of pharmaceutical products Sprimont · balance sheet 112,116 €
- Pharmacie LEFEBVRE Retail sale of pharmaceutical products Leuven · balance sheet 112,505 €
- PPPharmacy Retail sale of pharmaceutical products Ghent · balance sheet 106,768 €
- Merckx Retail sale of pharmaceutical products Wichelen · balance sheet 106,701 €
Frequently asked questions about Grodt
What is the revenue of Grodt?
Grodt files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Grodt?
In Belgium, the VAT number is the company number prefixed with BE: BE0789571288 for Grodt, if the company is VAT-registered. Its company number (CBE) is 0789.571.288.
Where is the registered office of Grodt?
According to the CBE register, the registered office of Grodt is in 1180 Uccle.
What is the equity of Grodt?
At the close of the 2025 financial year, the equity of Grodt amounts to 27,515 €, a solvency of 25.1% of total assets.
Who manages Grodt?
The register lists 2 active mandates at Grodt. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Grodt
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →